Literature DB >> 25698658

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.

A Russo1, M Falcone1, M Fantoni2, R Murri2, L Masucci3, P Carfagna4, M C Ghezzi1, B Posteraro5, M Sanguinetti3, M Venditti6.   

Abstract

The alterations occurring in the intestinal flora during Clostridium difficile infection (CDI) may promote the translocation of Candida to the blood and the development of candidaemia. The aim of our study was to analyse clinical findings of these patients to determine the risk factors associated with the development of candidaemia subsequent to CDI. We compared 35 patients with candidaemia subsequent to CDI with 105 patients with CDI. Patients with candidaemia showed more severe infections and higher mortality. The ribotype 027 strain and vancomycin treatment at ≥ 1000 mg/day were prevalent in patients developing candidaemia. CDI may predispose to the translocation of Candida.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Candida bloodstream infection; Candida colonization; Clostridium difficile infection; oral vancomycin; ribotype 027

Mesh:

Substances:

Year:  2015        PMID: 25698658     DOI: 10.1016/j.cmi.2014.12.024

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.

Authors:  Marco Falcone; Alessandro Russo; Federica Iraci; Paolo Carfagna; Paola Goldoni; Vincenzo Vullo; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

2.  Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study.

Authors:  D R Giacobbe; V Del Bono; P Bruzzi; S Corcione; M Giannella; A Marchese; L Magnasco; A E Maraolo; N Pagani; C Saffioti; S Ambretti; C S Cardellino; E Coppo; F G De Rosa; P Viale; C Viscoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-01       Impact factor: 3.267

3.  A Tale of Two Healthcare-associated Infections: Clostridium difficile Coinfection Among Patients With Candidemia.

Authors:  Sharon Tsay; Sabrina R Williams; Kaitlin Benedict; Zintars Beldavs; Monica Farley; Lee Harrison; William Schaffner; Ghinwa Dumyati; Anna Blackstock; Alice Guh; Snigdha Vallabhaneni
Journal:  Clin Infect Dis       Date:  2019-02-01       Impact factor: 9.079

4.  Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria.

Authors:  Rebecca A Drummond; Jigar V Desai; Emily E Ricotta; Muthulekha Swamydas; Clay Deming; Sean Conlan; Mariam Quinones; Veronika Matei-Rascu; Lozan Sherif; David Lecky; Chyi-Chia R Lee; Nathaniel M Green; Nicholas Collins; Adrian M Zelazny; D Rebecca Prevots; David Bending; David Withers; Yasmine Belkaid; Julia A Segre; Michail S Lionakis
Journal:  Cell Host Microbe       Date:  2022-05-13       Impact factor: 31.316

5.  Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.

Authors:  S Vallabhaneni; O Almendares; M M Farley; J Reno; Z T Smith; B Stein; S S Magill; R M Smith; A A Cleveland; F C Lessa
Journal:  Epidemiol Infect       Date:  2015-11-26       Impact factor: 4.434

6.  Interspecies Interactions between Clostridium difficile and Candida albicans.

Authors:  Pim T van Leeuwen; Jasper M van der Peet; Floris J Bikker; Michel A Hoogenkamp; Ana M Oliveira Paiva; Sarantos Kostidis; Oleg A Mayboroda; Wiep Klaas Smits; Bastiaan P Krom
Journal:  mSphere       Date:  2016-11-09       Impact factor: 4.389

7.  Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Lan-Yan Yang; Yu-Bin Pan; Mei-Yin Lai; Shih-Ming Chu; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Jang-Jih Lu
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

Review 8.  Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options.

Authors:  Mattia Trunfio; Silvia Scabini; Walter Rugge; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  Microorganisms       Date:  2022-06-23

9.  Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection.

Authors:  Alessandra Oliva; Lucia Aversano; Massimiliano De Angelis; Maria Teresa Mascellino; Maria Claudia Miele; Sergio Morelli; Riccardo Battaglia; Jessica Iera; Giovanni Bruno; Enrico Stefano Corazziari; Maria Rosa Ciardi; Mario Venditti; Claudio Maria Mastroianni; Vincenzo Vullo
Journal:  Open Forum Infect Dis       Date:  2019-12-03       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.